Boothbay Fund Management, LLC Curis Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $10,801 - $36,967	-15,213 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $35,142 - $78,042	15,213 New	15,213 $36,000
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $950,530 - $2.08 Million	-127,588 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$8.78 - $12.8 $329,408 - $480,230	-37,518 Reduced 22.72%	127,588 $1.44 Million
Q4 2020 Feb 12, 2021	BUY	$1.08 - $8.2 $91,914 - $697,869	85,106 Added 106.38%	165,106 $1.35 Million
Q3 2020 Nov 16, 2020	BUY	$0.95 - $1.42 $76,000 - $113,600	80,000 New	80,000 $94,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.